SEARCH

SEARCH BY CITATION

References

  • Abes S. Turner J. Ivanova G.D. Owen D. Williams D. Arzumanov A. Clair P. Gait M.J. Lebleu B. Efficient splicing correction by PNA conjugation to an R6-penetratin delivery peptide Nucleic Acids Res. 2007 35 44954502
  • Aoshiba K. Yokohori N. Nagai A. Alveolar wall apoptosis causes lung destruction and amphysematous changes Am. J. Respir. Cell Mol. Biol. 2003 28 555561
  • Arita M. Bianchini F. Aliberti J. Sher A. Chiang N. Hong S. Yang R. Petasis N.A. Serhan C.N. Stereochemical assignment, anti-inflammatory properties and receptors for the omega-3 lipid mediator resolving E1 J. Exp. Med. 2005 201 713722
  • Asai A. Oshima Y. Yamamoto Y. Uochi T.A. Kusaka H. Akinaga S. Yamashita Y. Pongracz K. Pruzan R. Wunder E. Piatyszek M. Li S. Chin A.C. Harley C.B. Gryaznov S. A novel telomerase template antagonist (GRN163) as a potential anticancer agent Cancer Res. 2003 63 39313939
  • Badag-Gorce F. Riley N. Nguyen V. Montgomery R.O. French B.A. Li F.W. Van Leeuwen W. Lungo L.W. McPhaul L.W. French S.W. The mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB1) Exp. Mol. Pathol. 2003 74 160167
  • Balali-Mood K. Ashley R.H. Hauss T. Bradshaw J.P. Neutron diffraction reveals sequence-specific membrane insertion of pre-fibrillar islet amyloid polypeptide and inhibition by rifampicin FEBS Lett. 2005 579 11431148
  • Beauvais D.M. Rapraeger A.C. Syndecans in tumor cell adhesion and signalling Reprod. Biol. Endocrinol. 2004 2 35
  • Belting M. Petersson P. Intracellular accumulation of secreted proteoglycans inhibits cationic lipid-mediated gene transfer. Co-transfer of glycosaminoglycans to the nucleus J. Biol. Chem. 1999 274 1937519382
  • Bjorklund J. Biverstahl H. Graslund A. Maler L. Brzezinski P. Real-time transmembrane translocation of penetratin driven by light-generated proton pumping Biophys. J. 2006 291 2931
  • Branden L.J. Mohamed A.J. Smith C.I. A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA Nat. Biotechnol. 1999 17 784787
  • Brummelkamp T.R. Bernards R. Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference Cancer Cell 2002 2 243251
  • Burlina F. Sagan S. Bolbach G. Chassaing G. A direct approach to quantification of the cellular uptake of cell-penetrating peptides using MALDI-TOF mass spectrometry Nat. Protoc. 2006 1 200205
  • Cartier R. Reszka R. Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems Gene Ther. 2002 9 157163
  • Chan S.A. Polo-Parada L. Landmesser L.T. Smith C. Adrenal chromaffin cells exhibit impaired granule trafficking in NCAM knockout mice, J Neurophysiol. 2005 94 10371047
  • Chiang C.M. Chien K.Y. Lin H.J. Lin J.F. Yeh H.C. Ho P.L. Wu W.G. Conformational change and inactivation of membrane phospholipid-related activity of cardiotoxin V from Taiwan cobra venom at acidic pH Biochemistry 1996 35 91679176
  • Conner S.D. Schmid S.L. Regulated portals of entry into the cell Nature 2003 422 3744
  • Console S. Marty C. Garcia-Echeverria C. Schwendener R. Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) ‘protein transduction domains’ promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans J. Biol. Chem. 2003 278 3510935114
  • Couchman J.R. Syndecans: proteoglycan regulators of cell-surface microdomains? Nat. Rev. Mol. Cell Biol. 2003 4 926937
  • Crombez L. Charnet A. Morris M.C. Aldrian-Herrada G. Heitz F. Divita G. A non-covalent peptide-based strategy for siRNA delivery Biochem. Soc. Trans. 2007 35 4446
  • Davidson T.J. Harel S. Arboleda V.A. Prunell G.F. Shelanski M.L. Greene L.A. Troy C.M. Highly efficient small interfering RNA delivery to primary mammalian neurons induces microRNA-like effects before mRNA degradation J. Neurosci. 2004 10 1004010046
  • De Fougerolles A. Vornlocher H.-P. Maraganore J. Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics Nat. Rev. Drug Discov. 2007 6 443453
  • Dehio C. Freissler E. Lanz C. Gomez-Duarte O.G. David G. Meyer T.F. Ligation of cell surface heparan sulphate proteoglycans by antibody-coated beads stimulates phagocytic uptake into epithelial cells: a model for cellular invasion by Neisseria gonorrhoeae Exp. Cell Res. 1998 242 528539
  • Derossi D. Joliot A.H. Chassaing G. Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 1994 269 1044410450
  • Deshayes S. Heitz A. Morris M.C. Charnet P. Divita G. Heitz F. Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis Biochemistry 2004a 43 14491457
  • Deshayes S. Gerbal-Chaloin S. Morris M.C. Aldrian-Herrada G. Charnet P. Divita G. Heitz F. On the mechanism of non-endosomial peptide-mediated cellular delivery of nucleic acids Biochim. Biophys. Acta 2004b 1667 141147
  • Deshayes S. Plenat T. Aldrian-Herrada G. Divita G. LeGrimellec C. Heitz F. Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes Biochemistry 2004c 43 76987706
  • Deshayes S. Morris M.C. Divita G. Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics Cell Mol. Life Sci. 2005 62 18391849
  • Deshayes S. Plénat T. Charnet P. Divita G. Molle G. Heitz F. Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration Biochim. Biophys. Acta 2006 1758 18461851
  • Deshayes S. Morris M.C. Divita G. Heitz F. Langel Ü. Interaction of cell penetrating peptide with model membrane Cell-Penetrating Peptides 2007 2nd edn Boca Raton CRC Press 139160
  • Dorsett Y. Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics Nat. Rev. Drug Discov. 2004 3 318329
  • Efimov V. Choob M. Buryakova A. Phelan D. Chakhmakhcheva O. PNA-related oligonucleotide mimics and their evaluation for nucleic acid hybridization studies and analysis Nucleosides Nucleotides Nucleic Acids 2001 20 419428
  • Eitzen G. Actin remodelling to facilitate membrane fusion Biochim. Biophys. Acta 2003 1641 175181
  • El-Andaloussi S. Holm T. Langel Ü. Cell-penetrating peptides: mechanism and applications Curr. Pharm. Design 2005 11 35973611
  • Elbashir S.M. Harborth J. Lendeckel W. Yalcin A. Weber K. Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 2001 411 494498
  • Elliott G. O'Hare P. Intercellular trafficking and protein delivery by a Herpesvirus structural protein Cell 1997 88 223233
  • Esbjorner E.K. Gräslung A. Nordën P. Langel Ü. Membrane interactions of cell-penetrating peptides Cell-Penetrating Peptides 2007 2nd edn Boca Raton CRC Press 109138
  • Esclatine A. Bellon A. Michelson S. Servin A.L. Quero A.M. Geniteau-Legendre M. Differentiation-dependent redistribution of heparan sulfate in epithelial intestinal Caco-2 cells leads to basolateral entry of cytomegalovirus Virology 2001 289 2333
  • Escriou V. Carriere M. Scherman D. Wils P. NLS bioconjugates for targeting therapeutic genes to the nucleus Adv. Drug Deliv. Rev. 2003 55 295306
  • Eum W.S. Kim D.W. Hwang I.K. Yoo K.Y. Kang T.C. Jang S.H. Choi H.S. Choi S.H. Kim Y.H. Kim S.Y. Kwon H.Y. Kang J.H. Kwon O.S. Cho S.W. Lee K.S. Park J. Won M.H. Choi S.Y. In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult Free Radical Biol. Med. 2004 37 16561669
  • Fawell S. Seery J. Daikh Y. Moore C. Chen L.L. Pepinsky B. Barsoum J. Tat-mediated delivery of heterologous proteins into cells Proc. Natl. Acad. Sci. U.S.A. 1994 91 664668
  • Fischer R. Fotin-Mleczek M. Hufnagel H. Brock R. Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides Chembiochem 2005 6 21262142
  • Fountaine T.M. Wood M.J. Wade-Martins R. Delivering RNA interference to the mammalian brain Curr. Gene Ther. 2005 5 399410
  • Frankel A.D. Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus Cell 1998 55 11891193
  • Futaki S. Suzuki T. Ohashi W. Yagami T. Tanaka S. Ueda K. Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 2001 276 58365840
  • Gait M.J. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues Cell. Mol. Life Sci. 2003 60 844853
  • Gallo G. Yee H.F. Letourneau P.C. Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility J. Cell Biol. 2002 158 12191228
  • Gallo G. Making proteins into drugs: assisted delivery of proteins and peptides into living neurons Methods Cell Biol. 2003 71 325338
  • Gariepy J. Kawamura K. Vectorial delivery of macromolecules into cells using peptide-based vehicles Trends Biotechnol. 2000 19 2126
  • Garnon J. Lachance C. Di Marco S. Hel Z. Marion D. Ruiz M.C. Newkirk M.M. Khandjian F.W. Radzioch D. Fragile X-related protein FXR1P regulates proinflammatory cytokine TNF expression at the post-transcriptional level J. Biol. Chem. 2005 280 57505763
  • Gehler S. Shaw A.E. Sarmiere P.D. Bamburg J.R. Letourneau P.C. Brain-derived neutrophic factor regulation of retinal growth cone filopodial dynamics is mediated through actin depolymerizing factor/cofilin J. Neurosci. 2004 24 1074110749
  • Gerbal-Chaloin S. Gondeau C. Aldrian-Herrada G. Heitz F. Gauthier-Rouvière C. Divita G. First step of the cell-penetrating peptide mechanism involves Rac1 GTPase-dependent actin-network remodelling Biol. Cell 2007 99 223238
  • Glover D.J. Lipps H.J. Jans D.A. Towards safe, non-viral therapeutic gene expression in humans Nat. Rev. Genet. 2005 6 299310
  • Gros E. Deshayes S. Morris M.C. Aldrian-Herrada G. Depollier J. Heitz F. Divita G. A non-covalent peptide-based strategy for protein and peptide nucleic acid delivery Biochim. Biophys. Acta 2006 1758 384393
  • Gryaznov S. Asai A. Oshima Y. Yamamoto Y. Pongracz K. Pruzan R. Wunder E. Piatyszek M. Li S. Chin A. Harley C. Akinaga S. Yamashita Y. Oligonucleotide N3′[RIGHTWARDS ARROW]P5′ thio-phosphoramidate telomerase template antagonists as potential anticancer agents Nucleosides Nucleotides Nucleic Acids 2003 22 577581
  • Hannon G.J. RNA interference Nature 2002 418 244251
  • Hommel J.D. Sears R.M. Georgescu D. Simmons D.L. DiLeone R.J. Local gene knockdown in the brain using viral-mediated RNA interference Nat. Med. 2003 9 15391544
  • Ignatovich I.A. Dizhe E.B. Pavlotskaya A.V. Akifiev B.N. Burov S.V. Orlov S.V. Perevozchikov A.P. Complexes of plasmid DNA with basic domain 47–57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways J. Biol. Chem. 2003 278 4262542636
  • Järver P. Langel Ü. The use of cell-penetrating peptides as a toll for gene regulation Drug Discov. Today 2004 9 395402
  • Jevsek M. Jaworski A. Polo-Parada L. Kim N. Fan J. Landmesser L.T. Burden S.J. CD24 is expressed by myofiber synaptic and regulates synaptic transmission Proc. Natl. Acad. Sci. U.S.A. 2006 103 63746379
  • Joliot A. Prochiantz A. Transduction peptides: from technology to physiology Nat. Cell Biol. 2004 6 189196
  • Kaplan I.M. Wadia J.S. Dowdy S.F. Cationic Tat peptide transduction domain enters cells by macropinocytosis J. Control. Release 2005 102 247253
  • Kim W.J. Christensen L.V. Jo S. Yockman J.W. Jeong J.H. Kim Y.H. Kim S.W. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma Mol. Ther. 2006 14 343350
  • Kong H.J. Mooney D.J. Microenvironmental regulation of biomacromolecular therapies Nat. Rev. Drug Discov. 2007 6 455463
  • Koppelhus U. Nielsen P.E. Cellular delivery of peptide nucleic acid Adv. Drug. Deliv. Rev. 2003 55 267280
  • Kowolik C.M. Yam P. Yu Y. Yee J.K. HIV vector production mediated by Rev protein transduction Mol. Ther. 2003 2 324331
  • Krauss U. Muller M. Stahl M. Beck-Sickinger A.G. in vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide Bioorg. Med. Chem. Lett. 2004 14 5154
  • Kumar P. Wu H. McBride J.L. Jung K.E. Kim M.H. Davidson B.L. Lee S.K. Shankar P. Manjunath N. Transvascular delivery of small interfering RNA to the central nervous system Nature 2007 448 3943
  • Labialle S. Dayan G. Gayet L. Rigal D. Gambrelle J. Baggetto L.G. New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein Nucleic Acids Res. 2004 32 38643876
  • Langel Ü. Cell-Penetrating Peptides: Processes and Applications Pharmacology and Toxicology series 2007 Boca Raton CRC Press
  • Langlois M.A. Boniface C. Wang G. Alluin J. Salvaterra P.M. Puymirat J. Rossi J.J. Lee N.S. Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells J. Biol. Chem. 2005 280 1694916954
  • Letoha T. Gaal S. Somlai C. Czajlik A. Perczel A. Penke B. Membrane translocation of penetratin and its derivatives in different cell lines J. Mol. Recognit. 2003 16 272279
  • Lewis D.L. Hagstrom J.E. Loomis A.G. Wolff J.A. Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice Nat. Genet. 2002 32 107108
  • Li Y. Heitz F. Le Grimellec C. Cole R.B. Fusion peptide—phospholipid noncovalent interactions as observed by nanoelectrospray FTICR-MS Anal. Chem. 2005 77 15561565
  • Lundberg M. Johansson M. Is VP22 nuclear homing an artefact? Nat. Biotechnol. 2001 19 713714
  • Lundberg M. Wikstrom S. Johansson M. Cell surface adherence and endocytosis of protein transduction domain Mol. Ther. 2003 8 143150
  • Lundberg P. El-Andaloussi S. Sutlu T. Johansson H. Langel U. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides FASEB J. 2007 11 26642671
  • Magzoub M. Gräslund A. Cell-penetrating peptides: small from inception to application Q. Rev. Biophys. 2004 37 147195
  • Maron M.B Folkesson H.G. Stader S.M. Walro J.M. PKA delivery to the distal lung air spaces increases alveolar liquid clearance after isoproterenol-induced alveolar epithelial PKA desensitization Am. J. Physiol. Lung Cell. Mol. Physiol. 2005 289 L349L354
  • Marthinet E. Divita G. Bernaud J. Rigal D. Baggetto L.G. Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter Gene Ther. 2000 7 12241233
  • Mattheakis L.C. Dias J.M. Choi Y.J. Gong J. Bruchez M.P. Liu J. Wang E. Optical coding of mammalian cells using semiconductor quantum dots Anal. Biochem. 2004 327 200208
  • McCaffrey A.P. Meuse L. Pham T.T. Conklin D.S. Hannon G.J. Kay M.A. RNA interference in adult mice Nature 2002 418 3839
  • McManus M.T. Sharp P.A. Gene silencing in mammals by small interfering RNAs Nat. Rev. Genet. 2002 3 737747
  • Meade B.R. Dowdy S.F. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides Adv. Drug Deliv. Rev. 2007 59 134140
  • Mery J. Granier C. Juin M. Brugidou J. Disulfide linkage to polyacrylic resin for automated Fmoc peptide synthesis. Immunochemical applications of peptide resins and mercaptoamide peptides Int. J. Pept. Protein Res. 1993 42 4452
  • Morris M.C. Vidal P. Chaloin L. Heitz F. Divita G. A new peptide vector for efficient delivery of oligonucleotides into mammalian cells Nucleic Acids Res. 1997 25 27302736
  • Morris M.C. Chaloin L. Mery J. Heitz F. Divita G. A novel potent strategy for gene delivery using a single peptide vector as a carrier Nucleic Acids Res. 1999a 27 35103517
  • Morris M.C. Robert-Hebmann V. Chaloin L. Mery J. Heitz F. Devaux C. Goody R.S. Divita G. A new potent HIV-reverse transcriptase inhibitor: a synthetic peptide derived from interface subunit domains J. Biol. Chem. 1999b 274 2494124946
  • Morris M.C. Chaloin L. Heitz F. Divita G. Translocating peptides and proteins and their use for gene delivery Curr. Opin. Biotechnol. 2000 11 461466
  • Morris M.C. Depollier J. Mery J. Heitz F. Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells Nat. Biotechnol. 2001 19 11731176
  • Morris M.C. Chaloin L. Choob M. Archdeacon J. Heitz F. Divita G. Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression Gene Ther. 2004a 11 757764
  • Morris K.V. Chan S.W. Jacobsen S.E. Looney D.J. Small interfering RNA-induced transcriptional gene silencing in human cells Science 2004b 305 12891292
  • Morris M.C. Depollier J. Mery J. Heitz F. Divita G. Celis J.E. A peptide carrier for the delivery of biologically active proteins into mammalian cells: application to the delivery of antibodies and therapeutic proteins Cell Biology: A Laboratory Handbook 2006 vol. 4 Elsevier Academic Press 1318
  • Morris M.C. Deshayes S. Simeoni F. Aldrian-Herrada G. Heitz F. Divita G. Langel Ü. A noncovalent peptide-based strategy for peptide and short interfering RNA delivery Cell-Penetrating Peptides 2007a 2nd edn Boca Raton CRC press 387408
  • Morris M.C. Gros E. Aldrian-Herrada G. Choob M. Archdeacon J. Heitz F. Divita G. A non-covalent peptide-based carrier for in vivo delivery of DNA mimics Nucleic Acids Res. 2007b 35 e49e59
  • Moschos S. Williams A. Lindsay M. Langel Ü. In vivo applications of cell-penetrating peptide Cell-Penetrating Peptides 2007 2nd edn Boca Raton CRC Press 423438
  • Moulton H.M. Moulton J.D. Arginine-rich cell-penetrating peptides with uncharged antisense oligomers Drug Discov. Today 2004 9 870875
  • Munoz-Morris M.A. Heitz F. Divita G. Morris M.C. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes, Biochem Biophys. Res. Commun. 2007 355 877882
  • Muratovska A. Eccles M.R. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells FEBS Lett. 2004 558 6368
  • Murriel C.L Dowdy S.F. Influence of protein transduction domains on intracellular delivery of macromolecules Expert Opin. Drug Deliv. 2006 3 739746
  • Nagahara H. Vocero-Akbani A.M. Snyder E.L. Ho A. Latham D.G. Lissy N.A. Becker-Hapak M. Ezhevsky S.A. Dowdy S.F. Transduction of full-length TAT fusion proteins into mammalian cells: TAp27kip1 induced cell migration Nat. Med. 1998 4 14491452
  • Nakase I. Niwa M. Takeuchi T. Sonomura K. Kawabata N. Koike Y. Takehashi M. Tanaka S. Ueda K. Simpson J.C. Jones A.T. Sugiura Y. Futaki S. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement Mol. Ther. 2004 10 10111022
  • Nakase I. Tadokoro A. Kawabata N. Takeuchi T. Katoh H. Hiramoto K. Negishi M. Nomizu M. Sugiura Y. Futaki S. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis Biochemistry 2007 46 492550
  • Nan L. Wu Y. Bardag-Gorce F. Li J. French B.A. Wilson L. Khanh S. Nguyen T. French S.W. RNA interference of VCP/p97 increases Mallory body formation Exp. Mol. Pathol. 2005 78 19
  • Nguyen Q.N. Chavli R.V. Marques J.T. Jr Conrad P.G. Wang D. He W. Belisle B.E. Zhang A. Pastor L.M. Witney F.R. Morris M. Heitz F. Divita G. Williams R. McMaster G.K. Light controllable siRNAs regulate gene suppression and phenotypes in cells Biochim. Biophys. Acta 2006 1758 394403
  • Niidome T. Huang L. Gene therapy progress and prospects: non viral vectors Gene Ther. 2002 10 16471652
  • Nordera P. Serra M.D. Menestrina G. The adsorption of Pseudomonas aeruginosa exotoxin A to phospholipid monolayers is controlled by pH and surface potential Biophys. J. 1997 73 14681478
  • Ogris M. Wagner E. Targeting tumors with non-viral gene delivery systems Drug Discov. Today 2002 7 479485
  • Opalinska J.B. Gewirtz A.M. Nucleic-acid therapeutics: basic principles and recent applications. Nucleic-acid therapeutics: basic principles and recent applications Nat. Rev. Drug Discov. 2002 1 503514
  • Padari K. Säälik P. Hansen M. Koppel K. Raid R. Langel U. Pooga M. Cell transduction pathways of transportans Bioconjug. Chem. 2005 16 13991410
  • Palm C. Jayamanne M. Kjellander M. Hällbrink M. Peptide degradation is a critical determinant for cell-penetrating pepetide uptake Biochim. Biophys. Acta 2007 1768 17691776
  • Pandey A.V. Mellon S.H. Miller W.L. Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17 J. Biol. Chem. 2003 278 28372844
  • Park C.B. Yi K.S. Matsuzaki K. Kim M.S. Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II Proc. Natl. Acad. Sci. U.S.A. 2000 97 82458250
  • Pastor L. Chavli R. Divita G. He W. Heitz F. McMaster G. Morris M. Nguyen Q. Simeoni F. Zhang A. Transfection of differentiated 3T3-L1 adipocytes using DeliverX Plus siRNA reagent solution Application Note 2006 http:www.panomics.comproduct.phpproduct_id42
  • Payne C. Rawe V. Ramalho-Santos J. Simerly C. Schatten G. Preferentially localized dynein and perinuclear dynactin associate with nuclear pore complex proteins to mediate genomic union during mammalian fertilization J. Cell Sci. 2003 116 47274738
  • Pichon C. Monsigny M. Roche A.C. Intracellular localization of oligonucleotides: influence of fixative protocols Antisense Nucleic Acid Drug Dev. 1999 9 8993
  • Plenat T. Deshayes S. Boichot S. Milhiet P.E. Cole R. Heitz F. Le Grimellec C. Interaction of primary amphipathic cell-penetrating peptides with phospholipid-supported monolayers Langmuir 2004 20 92559261
  • Pooga M. Soomets U. Hallbrink M. Valkna A. Saar K. Rezaei K. Kahl U. Hao J.X. Xu X.J. Wiesenfeld-Hallin Z. Hokfelt T. Bartfai T. Langel U. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo Nat. Biotechnol. 1998 16 857861
  • Pooga M. Kut C. Kihlmark M. Hallbrink M. Fernaeus S. Raid R. Land T. Hallberg E. Bartfai T. Langel U. Cellular translocation of proteins by transportan FASEB J. 2001 8 14511453
  • Pratt R.L. Kinch M.S. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade Oncogene 2002 21 76907699
  • Pujals S. Fernandez-Carneado J. Lopez-Iglesias C. Kogan M.J. Giralt E. Mechanistic aspects of CPP-mediated intracellular drug delivery: relevance of CPP self-assembly Biochim. Biophys. Acta 2006 1758 264279
  • Rawe V.Y. Payne C. Navara C. Schatten G. WAVE1 intranuclear trafficking is essential for genomic and cytoskeletal dynamics during fertilization: cell-cycle-dependent shuttling between M-phase and interphase nuclei Dev. Biol. 2004 276 253267
  • Richard J.P. Melikov K. Vives E. Ramos C. Verbeure B. Gait M.J. Chernomordik L.V. Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 2003 278 585590
  • Richard J.P. Melikov K. Brooks H. Prevot P. Lebleu B. Chernomordik V. Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors J. Biol. Chem. 2005 280 1530015306
  • Rittner K. Benavente A. Bompard-Sorlet A. Heitz F. Divita G. Brasseur R. Jacobs E. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther. 2002 5 104114
  • Rothbard J.B. Jessop T.C. Lewis R.S. Murray B.A. Wender P.A. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells J. Am. Chem. Soc. 2004 126 95069507
  • Rudolph C. Plank C. Lausier J. Schillinger U. Muller R.H. Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells J. Biol. Chem. 2003 278 1141111418
  • Rusnati M. Tulipano G. Spillmann D. Tanghetti E. Oreste P. Zoppetti G. Giacca M. Presta M. Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides. J Biol. Chem. 1999 274 2819828205
  • Säälik P. Elmquist A. Hansen M. Padari K. Saar K. Viht K. Langel U. Pooga M. Protein cargo delivery properties of cell-penetrating peptides. A comparative study Bioconjug. Chem. 2004 15 12461253
  • Saoncella S. Echtermeyer F. Denhez F. Nowlen J.K. Mosher D.F. Robinson S.D. Hynes R.O. Goetinck P.F. Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers Proc. Natl. Acad. Sci. U.S.A. 1999 96 28052810
  • Schmidt M.C. Rothen-Rutishauser B. Rist B. Beck-Sickinger A. Wunderli-Allenspach H. Rubas W. Sadee W. Merkle H.P. Translocation of human calcitonin in respiratory nasal epithelium is associated with self assembly in lipid membrane Biochemistry 1998 37 1658216590
  • Schwarze S.R. Ho A. Vocero-Akbani A. Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse Science 1999 285 15691572
  • Simeoni F. Morris M.C. Heitz F. Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells Nucleic Acids Res. 2003 31 27172724
  • Simeoni F. Morris M.C. Heitz F. Divita G. Peptide-based strategy for siRNA delivery into mammalian cells Methods Mol. Biol. 2005 309 251264
  • Snyder E.L. Dowdy S.F. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo Expert Opin. Drug Deliv. 2005 2 4351
  • Song E. Lee S.K. Wang J. Ince N. Ouyang N. Min J. Chen J. Shankar P. Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis Nat. Med. 2003 9 347351
  • Song E. Zhu P. Lee S.K. Chowdhury D. Kussman S. Dykxhoorn D.M. Feng Y. Palliser D. Weiner D.B. Shankar P. Marasco W.A. Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors Nat. Biotechnol. 2005 23 709717
  • Soutschek J. Akinc A. Bramlage B. Charisse K. Constien R. Donoghue M. Elbashir S. Geick A. Hadwiger P. Harborth J. John M. Kesavan V. Lavine G. Pandey R.K. Racie T. Rajeev K.G. Röhl I. Toudjarska I. Wang G. Wuschko S. Bumcrot D. Koteliansky V. Limmer S. Manoharan M. Vornlocher H.P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 2004 432 173178
  • Takeshita F. Minakuchi Y. Nagahara S. Honma K. Sasaki H. Hirai K. Teratani T. Namatame N. Yamamoto Y. Hanai K. Kato T. Sano A. Ochiya T. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo Proc. Natl. Acad. Sci. U.S.A. 2005 102 1217712182
  • Tang X. Molina M. Amar S. p53 short peptide regulateds lipopolysaccharide -induced tumor necrosis factor-a-factor/cytokine expression Cancer Res. 2007 67 13081316
  • Tatulian S. Tamm L. Secondary structure, orientation, oligomerization, and lipid interactions of the transmembrane domain of influenza hemagglutinin Biochemistry 2000 39 496507
  • Terrone D. Sang S.L. Roudaia L. Silvius J.R. Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential Biochemistry 2003 42 1378713799
  • Thomas A. Deshayes S. Decaffmeyer M. Van Eyck M.H. Charloteaux B. Brasseur R. Prediction of peptide structure: how far are we? Proteins 2006 65 889897
  • Thoren P.E. Persson D. Isakson P. Goksor M. Onfelt A. Norden B. Uptake of analogs of penetratin, Tat(48–60) and oligoarginine in live cells Biochem. Biophys. Res. Commun. 2003 307 100107
  • Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 2005 4 145160
  • Tung C.H. Mueller S. Weissleder R. Novel branching membrane translocational peptide as gene delivery vector Bioorg. Med. Chem. 2002 10 36093614
  • Van Mau N. Vié V. Chaloin L. Lesniewska E. Heitz F. Le Grimellec C. Lipid induced organization of a primary amphipathic peptide. A coupled AFM—monolayer study J. Membr. Biol. 1999 167 241249
  • Veldhoen S. Laufer S.D. Trampe A. Restle T. Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect Nucleic Acids Res. 2006 34 65616573
  • Verger R. Pattus F. Spreading of membranes at the air/water interface Chem. Phys. Lipids 1976 16 285291
  • Vives E. Brodin P. Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 1997 272 1601016017
  • Wadia J. Stan R.V. Dowdy S. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 2004 10 310315
  • Wender P.A. Mitchell D.J. Pattabiraman K. Pelkey E.T. Steinman L. Rothbard J.B. The design, synthesis and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. U.S.A. 2000 97 1300313008
  • Wiethoff C.M. Smith J.G. Koe G.S. Middaugh C.R. The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans J. Biol. Chem. 2001 276 3280632813
  • Wimley W.C. White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces Nat. Struct. Biol. 1996 3 842848
  • Xia H. Mao Q. Paulson H.L. Davidson B.L. siRNA-mediated gene silencing in vitro and in vivo Nat. Biotechnol. 2002 20 10061010
  • Yoneda A. Couchman J.R. Regulation of cytoskeletal organization by syndecan transmembrane proteoglycans Matrix Biol. 2003 1 2533
  • Zatsepin T.S. Turner J.J. Oretskaya T.S. Gait M.J. Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing Curr. Pharm. Des. 2005 11 36393654
  • Zeineddine D. Papadimou E. Chebli K. Gineste M. Liu J. Grey C. Thurig S. Behfar A. Wallace V.A. Skerjanc I.S. Puceat M. Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development Dev Cell. 2006 11 535546
  • Ziegler A. Nervi P. Dürrenberger M. Seelig J. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence Biochemistry 2005 44 138148